极低尼古丁含量香烟的代偿性吸烟:系统评价与Meta分析
Meta分析纳入7项美国试验的2454名参与者,主要终点为干预结束时每日吸烟总支数和呼出气CO暴露。结果显示,与NNCs相比,VLNCs组平均每日吸烟支数和CO暴露均未增加;估计仅0.8%的参与者吸烟增加(最大预期增加3.3支/日),8.1%的参与者CO暴露增加(随机化后6周最大预期增加4.2 ppm)。结论认为,若FDA实施低尼古丁产品标准,广泛代偿性吸烟不太可能发生。
要点
- Meta分析(7项美国试验,2454名参与者)估计仅0.8%的参与者吸烟增加,最大预期增加3.3支/日。
- 估计8.1%的参与者CO暴露增加,随机化后6周最大预期增加4.2 ppm。
- VLNCs含尼古丁约比标准香烟低95%,研究干预时长为3—20周。
- 结论支持FDA推行低尼古丁产品标准时,广泛代偿性吸烟不太可能发生。
适用人群与场景
- 每日或非每日吸烟的青少年和成人,有无戒烟意愿均可;纳入RCT的干预条件为吸VLNCs 3—20周。
- 原文未提及急诊/ICU场景或特定病情阶段。
诊断标准与关键阈值
- 纳入标准:RCT,报告吸VLNCs 3—20周的干预条件;对照条件多样但通常为吸NNCs。
- VLNCs含尼古丁约比标准香烟低95%。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- Meta分析纳入7项美国试验的2454名参与者;主要终点为干预结束时每日吸烟总支数和呼出气CO暴露。
- 与NNCs相比,VLNCs组平均每日吸烟支数和CO暴露均未增加;估计0.8%的参与者吸烟增加(最大预期增加3.3支/日),8.1%的参与者CO暴露增加(随机化后6周最大预期增加4.2 ppm)。
- 关键次要终点和不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析(纳入RCT),遵循PRISMA指南,由两名研究者提取数据。
- 证据等级或推荐强度:原文未提及。
- 局限:原文未明确列出;设计上纳入试验的对照条件多样,Meta分析仅基于7项美国试验的子集。
对床旁实践的改变
- 原文结果提示,在吸VLNCs 3—20周的人群中未见平均每日吸烟支数或CO暴露增加,广泛代偿性吸烟不太可能发生;该结论来自吸烟青少年和成人研究,不直接适用于急诊/ICU临床处置。
- 常见陷阱:不能将群体平均未增加理解为个体绝不会代偿(原文估计0.8%吸烟增加、8.1% CO暴露增加)。
指南或共识出处
- 原文未提及指南或共识名称;研究对象为FDA低尼古丁产品标准相关证据。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The US Food and Drug Administration (FDA) is pursuing a low-nicotine product standard for cigarettes and other combusted tobacco. Very low nicotine content cigarettes (VLNCs) contain approximately 95% less nicotine than standard cigarettes. A key concern is that people who smoke may increase their smoking to compensate for the reduced nicotine levels, which would be a major unintended consequence of the regulation.
OBJECTIVE: To examine whether people who smoke increase their smoking behavior and/or smoke exposure when smoking VLNCs for extended periods.
DATA SOURCES: A comprehensive search was performed across multiple databases (eg, PubMed Medline, Embase, Web of Science, Cochrane Library, and CINAHL) on July 5, 2024, to identify randomized clinical trials (RCTs) evaluating VLNCs.
STUDY SELECTION: Eligible RCTs reported treatment conditions comprising smoking VLNCs for 3- to 20-week periods. Control conditions varied but typically included smoking normal nicotine content cigarettes (NNCs).
DATA EXTRACTION AND SYNTHESIS: This study followed the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines. Two investigators performed the data extraction.
MAIN OUTCOMES AND MEASURES: Outcomes included the total number of cigarettes smoked per day and exhaled breath carbon monoxide (CO) exposure at the end of the intervention.
RESULTS: Seventeen RCTs (16 from the US and 1 from New Zealand) published between 2010 and 2024 met inclusion criteria, representing 5500 adolescents and adults who smoked cigarettes daily or nondaily, with or without quit interest. The pooled meta-analysis included a subset of 2454 participants from 7 US trials. No trials reported increases in the mean number of cigarettes smoked per day or CO exposure at the end of the intervention among participants assigned to VLNCs vs NNCs. It was estimated that 0.8% of participants could expect an increase in smoking, with a maximum expected increase of 3.3 cigarettes smoked per day, and 8.1% could expect an increase in CO exposure, with a maximum expected increase of 4.2 parts per million 6 weeks after randomization if assigned VLNCs vs NNCs.
CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis of VLNC RCTs found minimal evidence of compensation among people assigned to smoke VLNCs. The findings suggest that widespread compensatory smoking is unlikely to occur if the FDA implements a low-nicotine product standard for cigarettes and other combusted tobacco.
参考来源
- Denlinger-Apte RL, Ji Z, Harwood EA, et al. Compensatory Smoking With Very Low Nicotine Content Cigarettes: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2026. PMID: 42455573. doi:10.1001/jamanetworkopen.2026.22543
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。